[Mediators in shock processes: pathogenetic and therapeutic problems].
D000109:Acetylcholine / Q000502:physiology; D000305:Adrenal Cortex Hormones / Q000502:physiology; D000707:Anaphylaxis / Q000503:physiopathology; D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D001808:Blood Vessels / Q000503:physiopathology; D002463:Cell Membrane Permeability; D003165:Complement System Proteins / Q000502:physiology; D004285:Dogs; D004731:Endotoxins; D000882:Haplorhini; D006632:Histamine / Q000502:physiology; D006801:Humans; D007705:Kinins / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D010740:Phospholipases / Q000502:physiology; D011817:Rabbits; D012701:Serotonin / Q000502:physiology; D012769:Shock / Q000201:enzymology / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D012772:Shock, Septic / Q000503:physiopathology; D014357:Trypsin / Q000502:physiology
D000305:Adrenal Cortex Hormones; D004731:Endotoxins; D007705:Kinins; D000804:Angiotensin II; D012701:Serotonin; D006632:Histamine; D003165:Complement System Proteins; D010740:Phospholipases; D014357:Trypsin; D000109:Acetylcholine; D009638:Norepinephrine
Zur Frage der Mediatoren bei Schockprozessen: Pathogenetische und therapeutische Probleme.